Status:

COMPLETED

Multicenter Study to Develop a Risk Model for Early Major Cardiovascular Events

Lead Sponsor:

Instituto Mexicano del Seguro Social

Conditions:

Acute Coronary Syndromes

Eligibility:

All Genders

18-90 years

Brief Summary

Through the National Registry of patients with ACS in the IMSS (RENASCA IMSS) the investigators will know the real world in terms of risk factors frequency, clinical presentation and its complications...

Detailed Description

Introduction: Ischemic heart diseases as the leading cause of death in Mexico are mainly due to acute myocardial infarction. In this sense, reperfusion strategies are the cornerstone of treatment to r...

Eligibility Criteria

Inclusion

  • Consecutive patients of any gender between 18 and 90 years old
  • Diagnosed with Acute Coronary Syndrome (STEMI/ NSTEMI/ Unstable angina - according to international diagnostic criteria - ACC / AHA / ESC)

Exclusion

  • Cardiomyopathies
  • Congenital Disease
  • Acute Pulmonary Embolism

Key Trial Info

Start Date :

August 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2020

Estimated Enrollment :

21827 Patients enrolled

Trial Details

Trial ID

NCT02255344

Start Date

August 1 2014

End Date

February 1 2020

Last Update

February 11 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gabriela Borrayo Sanchez

Mexico City, Mexico, 06720